Leung, Janice

Published purpose

The CIHR HIV/AIDS Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI (as identified in the Public Health Agency of Canada’s pan-Canadian STBBI framework for action). This includes, but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR Research Themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research. Research that focuses on key populations identified by Canada’s pan-Canadian STBBI framework for action is highly encouraged. Information on the strategic directions of the CIHR HIV/AIDS Research Initiative can be found in the CIHR HIV/AIDS Research Initiative: Strategic Plan (2015-2020).